| Authors: |
Kordowitzki P; Department of Basic and Preclinical Sciences, Nicolaus Copernicus University, Torun, Poland. paul.kordowitzki@charite.de.; Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, USA. paul.kordowitzki@charite.de.; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité, University Medicine Berlin, Augustenburgerplatz 1, Berlin, Germany. paul.kordowitzki@charite.de., Joshi S; Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, USA., Gong X; Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, USA., Ying AK; T. H. Chan School of Public Health, Harvard University, Boston, USA., Wyroba J; Malopolski Institute of Fertility Diagnostics and Treatment - KrakOvi, Krakow, Poland.; Fertility Disorders Clinic, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland., Kochan J; Malopolski Institute of Fertility Diagnostics and Treatment - KrakOvi, Krakow, Poland., Haigis MC; Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, USA. |